Pricing
reMYND drives the development of disease-modifying treatments against protein misfolding disorders.
Industries
Headquarters
Employees
Links
Full screen
Gerard Griffioen
View all
3 people · 0 jobs
1 person · 0 jobs
HQ
6 people · 0 jobs
Galapagos
4 followers
Sutro Biopharma
3 followers
Active Motif
Dyno Therapeutics
Janux Therapeutics
1 follower
Kpler
16 followers
QuellTX
Eikon Therapeutics
Sanofi
281 followers
Gilead Sciences
159 followers
Regeneron
130 followers
Explore companies